The ISMS multidisciplinary team has a proven track record of successful innovative market access assessment and implementation in biotech and pharma. We provide valuation of assets and substantiate value to ensure product reimbursement with a good price positioning, both in support of early development and to realize launch. With our multidisciplinary approach, bridging science and business, we provide a broad experience in terms of drug development (target product profile, outcome selection), health economics (value dossiers, pricing, cost-effectiveness and budget impact models) and further value & scientific communication, stakeholder negotiations and business & analytics modelling. We work with global pharma companies as well as biotech companies, and are passionate to share our experience with you!
MindBytes is a spin-off company of ISMS, and a ‘game changer’ in evidence-based learning solutions such as serious games that focus on behavioral change, such as games that provide insight to caregivers, games that capture patient preferences beyond traditional clinical outcomes, and e-learnings and dashboards.